Caixin App
Newsletter
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Editorial & Opinion
Weekend Long Read
Research & Analysis
Lifestyle
Books & Arts
Blog
Video
Caixin Weekly Sneak Peek
Topics
Asia New Vision Forum
War in Ukraine
Evergrande Crisis
ESG & Carbon Goals
China-U.S. Rivalry
Coronavirus
Hobbled Huawei
Digital Currency
Fintech / Internet Finance
Selected
CX Daily
Weekly Must-Read
Energy Insider
Economic Indexes
Caixin Explains
Reg Watch
Subscriber Events
ThinkChina
The Wall Street Journal
News Graphics
Market Data
Company Index
Podcast
Highlights
Newsletter
Events
ESG
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
"Fosun"
Daily Tech Roundup: Alibaba’s Plans for Ele.me, AI Model Developers’ Watershed Moment
BabyTree Group’s co-chairman, Wang Huainan, and several executives at Chinese conglomerate
Fosun
Baby Platform’s War of Words With Ex-CFO Sparks a Second Police Probe
, and several executives at Chinese conglomerate
Fosun
International Ltd., a major BabyTree shareholder
Former Yoozoo Executive Sentenced to Death for Fatally Poisoning Chairman
worked at well-known financial conglomerate
Fosun
Group before joining Yoozoo. He resigned from
In Depth: Behind China’s Struggle to Bring Down Drug-Resistant TB
, authorized a subsidiary of Shanghai
Fosun
Pharmaceutical Group Co. Ltd. (600196.SH) to sell it on the
CX Daily: Feed Giant New Hope Navigates Downside of Boom-Bust Cycle
2019. Cancer /
Fosun
Kite launches China’s first outcome-based payment plan for CAR-T
Shanghai Composite Index Rose 0.15% on Monday
amid growing concerns at tech companies teaming up with banks ·
Fosun
Kite Launches China’s First
Fosun
Kite Launches China’s First Outcome-based Payment Plan for CAR-T Therapy
Fosun
Kite Biotechnology Co. Ltd. on Thursday launched a pay-for-performance plan for its cell
Shanghai
Fosun
Pharmaceutical(Group) Co.,Ltd.’s Net Profit Dropped 3.8% in First Three Quarters of 2023
Shanghai
Fosun
Pharmaceutical(Group) Co.,Ltd. (上海复星医药(集团)股份有限公司) ( 600196.SH ) reported a net
Shanghai
Fosun
Pharmaceutical(Group) Co.,Ltd.’s Net Profit Dropped 3.8% in First Three Quarters of 2023
Shanghai
Fosun
Pharmaceutical(Group) Co.,Ltd. (上海复星医药(集团)股份有限公司) ( 600196.SH ) reported a net
Shanghai
Fosun
Pharmaceutical(Group) Co.,Ltd.’s Net Profit Rose 11% in First Half of 2023
Shanghai
Fosun
Pharmaceutical(Group) Co.,Ltd. (上海复星医药(集团)股份有限公司) ( 600196.SH ) reported a net
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通